James Nathanielsz - CEO/CFO, Director at Propanc Biopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO/CFO, Director
Issuer Symbol
PPCB on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Nathanielsz since 06 Jan 2025

Holdings reported by James Nathanielsz for Propanc Biopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock, par value $0.001 5,928,004 17 Aug 2021 North Horizon Investments Pty Ltd. as Trustee for Nathanielsz Family Trust
Common stock, par value $0.001 2,800,000 17 Aug 2021 By Spouse

Transactions reported by James Nathanielsz for Propanc Biopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.